Research and Markets: Future Horizons and Growth Strategies in the Global Therapeutic Drug Monitoring (TDM) Market 2015: Supplier Shares and Country Forecasts

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/w8drkx/future_horizons) has announced the addition of the "Future Horizons and Growth Strategies in the Global Therapeutic Drug Monitoring (TDM) Market 2015: Supplier Shares and Country Forecasts" report to their offering.

This new 313-page report contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.

Future Horizons and Growth Strategies in the Global Therapeutic Drug Monitoring (TDM) Market 2015 is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and develop effective strategic responses. The study provides five-year forecasts for major TDM assays, compares features of leading analyzers, and profiles key competitors.

The report provides test volume and sales forecasts by country and market segment for the following assays:

  • Amikacin
  • Carbamazepine
  • Cyclosporin
  • Digoxin
  • Everolimus
  • Gentamicin
  • Levetiracetam
  • Lithium
  • Methotrexate
  • NAPA/Procainamide
  • Phenobarbital
  • Phenytoin
  • Quinidine
  • Sirolimus
  • Tacrolimus
  • Theophylline
  • Tobramycin
  • Topirimate
  • Valproic Acid
  • Vancomycin

For more information visit http://www.researchandmarkets.com/research/w8drkx/future_horizons.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics